Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade

Published:2020-05-29 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Chuang Yu-Chen,Tseng Jen-Chih,Huang Li-Rung,Huang Chun-Ming,Huang Chi-Ying F.,Chuang Tsung-Hsien

Funder

National Health Research Institutes

Ministry of Science and Technology, Taiwan

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference210 articles.

1. The Intriguing History of Cancer Immunotherapy;Dobosz;Front Immunol,2019

2. Immunotherapy of cancers comes of age;Yousefi;Expert Rev Clin Immunol.,2017

3. A review on imiquimod therapy and discussion on optimal management of basal cell carcinomas;Kamath;Clin Drug Investig.,2018

4. Imiquimod in dermatology: an overview;Hanna;Int J Dermatol.,2016

5. Modes of action of TLR7 agonists in cancer therapy;Kobold;Immunotherapy.,2014

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Participation of TLRs in cancer immunopathogenesis and drug resistance via interacting with immunological and/or non-immunological signaling pathways as well as lncRNAs;International Immunopharmacology;2024-10

2. Novel prophylactic and therapeutic multi-epitope vaccine based on Ag85A, Ag85B, ESAT-6, and CFP-10 of Mycobacterium tuberculosis using an immunoinformatics approach;Osong Public Health and Research Perspectives;2024-08-31

3. Synergistic Effects of Metal–Organic Nanoplatform and Guanine Quadruplex-Based CpG Oligodeoxynucleotides in Therapeutic Cancer Vaccines with Different Tumor Antigens;Vaccines;2024-06-11

4. Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model;Cellular Oncology;2024-04-26

5. Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions;Cell & Bioscience;2024-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3